Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-368-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- Determination of bisphenol AF (BPAF) in tissues, serum, urine and feces of orally dosed rats by ultra-high-pressure liquid chromatography–electrospray tandem mass spectrometry
- Author:
- Yang et al.
- Year:
- 2 012
- Bibliographic source:
- Journal of Chromatography B, 901 (2012) 93– 97
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- Only 1 dose rate tested with no justification provided as to why this would be sufficient. Presence of metabolites not mentioned.
- GLP compliance:
- no
Test material
- Reference substance name:
- 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol
- Cas Number:
- 1478-61-1
- Molecular formula:
- C15H10F6O2
- IUPAC Name:
- 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Stock solution (in methanol) stored at -20 ºC.
- Stability under test conditions: Not required (ADME study- with UPLC/MS analysis throughout testing period)
- Solubility and stability of the test substance in the solvent/vehicle: Stock solution prepared at 1 mg/L.
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: Not reported
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Dissolved in methanol.
- Preliminary purification step (if any): n/a
- Final dilution of a dissolved solid, stock liquid or gel: 1 mg/L stock solution prepared, in methanol.
- Final preparation of a solid: n/a
FORM AS APPLIED IN THE TEST (if different from that of starting material): Applied as a liquid.
OTHER SPECIFICS: n/a - Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Academy of Military Medical Sciences, China.
- Age at study initiation: 8 - 9 weeks old
- Weight at study initiation: 250 - 300 g
- Housing: Housed individually in steel metabolism cages.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25 ºC
- Humidity (%): Not reported
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12:12 light: dark
IN-LIFE DATES: Not reported
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Dosing solutions were prepared from a 1 mg/L methanol stock solution. Details on the preparation of the dose solutions are not reported.
DIET PREPARATION
- Rate of preparation of diet (frequency): Not reported
- Mixing appropriate amounts with (Type of food): n/a
- Storage temperature of food: n/a - Duration and frequency of treatment / exposure:
- Individuals were treated daily for 2 weeks.
Doses / concentrations
- Dose / conc.:
- 10 mg/kg bw/day (nominal)
- No. of animals per sex per dose / concentration:
- 4
- Control animals:
- yes
- Positive control reference chemical:
- No
- Details on study design:
- - Dose selection rationale: Approximately 350-fold lower than the published acute LD50 data in rats.
- Rationale for animal assignment (if not random): Not reported - Details on dosing and sampling:
- TOXICOKINETIC / PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces, kidney, liver, testis, adipose and muscle.
- Time and frequency of sampling: At the end of the treatment period.
- Other: n/a
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled (delete / add / specify): urine, faeces, tissues (as above).
- Time and frequency of sampling: 1 sampling interval at the end of the treatment period (Day 14).
- From how many animals: 4
- Method type(s) for identification HPLC-MS-MS
- Limits of detection and quantification: Signal: noise ratio of 3:1 and 10:1 for LOD and LOQ, respectively, yielded quantification levels of 1 µg/kg for liver, muscle, adipose, kidney and urine samples; and 3 µg/kg for faeces.
- Other: n/a
TREATMENT FOR CLEAVAGE OF CONJUGATES (if applicable): Enzymatic hydrolysis - Statistics:
- A statistical analysis was performed by SPSS 16.0 to compare the difference in BPAF concentrations between samples with and without enzymatic hydrolysis, using the Wilcoxon Signed Ranks Test. The results of the analysis would dictate if the enzymatic hydrolysis procedure should be adopted in the test.
Results and discussion
- Preliminary studies:
- Recovery studies were performed at three fortification levels, which were selected according to the sensitivity of each matrix. The mean recoveries ranged from 71.0% to 102.3% with relative standard deviations of no more than 13.2% (n = 6).
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Bisphenol-AF was poorly adsorbed with the vast majority of the test item excreted in the faeces ( > 10 mg/kg).
- Details on distribution in tissues:
- Bisphenol-AF was found in highest concentrations in liver and kidney tissues and serum. Maximum concentrations of 1637.5 µg/kg were observed in liver tissue (after enzymatic hydrolysis).
- Details on excretion:
- Faecal excretion was the major route of elimination, and urinary excretion the secondary route.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Metabolites were not formally identified. The majority of bisphenol-AF was present in its conjugate form (> 86 %).
Bioaccessibility (or Bioavailability)
- Bioaccessibility (or Bioavailability) testing results:
- Not determined
Any other information on results incl. tables
Table 1 Concentration of bisphenol-AF in orally dosed rats
Tissues and excreta |
Concentration (µg/kg) |
|||||||
Without enzymatic hydrolysis |
After enzymatic hydrolysis |
|||||||
Rat 1 |
Rat 2 |
Rat 3 |
Rat 4 |
Rat 1 |
Rat 2 |
Rat 3 |
Rat 4 |
|
Liver |
78.1 |
141.0 |
437.5 |
190.5 |
1210.2 |
1376.3 |
1637.5 |
1496.6 |
Muscle |
8.1 |
10.0 |
12.8 |
17.1 |
44.3 |
20.1 |
17.6 |
19.5 |
Adipose |
30.3 |
30.3 |
39.3 |
40.1 |
62.7 |
47.2 |
42.1 |
57.8 |
Testis |
15.3 |
16.0 |
21.5 |
24.0 |
66.0 |
50.0 |
68.0 |
47.0 |
Kidney |
31.4 |
28.3 |
56.3 |
45.5 |
880.3 |
387.0 |
372.5 |
431.3 |
Serum |
3.4 |
3.2 |
3.9 |
4.3 |
1075.3 |
358.8 |
312.4 |
431.3 |
Urine |
31.5 |
17.0 |
17.6 |
25.5 |
177.6 |
47.5 |
25.7 |
59.8 |
Faeces |
424682.4 |
449908.6 |
337844.6 |
146468.7 |
545266.9 |
469864.7 |
370004.5 |
223646.9 |
Applicant's summary and conclusion
- Conclusions:
- Bisphenol-AF was poorly adorbed to the rat GI system where concentrations of test item greater than the application rate were observed in the faeces of individuals, indicating low potential for bioaccumulation. The highest level of bisphenol-AF were found in the liver, kidneys and serum. Extractions performed with and without enzyme hydrolysis indicated that the vast majority of recovered test item was present in its conjugated form, indicative of a test item that is readily metabolised by the liver. Faeces were confirmed as the major route of excretion of the test item with urine a secondary route.
- Executive summary:
In a metabolism study bisphenol-AF (98 % purity), was administered to 4 male Sprague-Dawley rats over 14 consecutive days by oral gavage at a dose level of 10 mg/kg bw/day.
High levels of BPAF were detected in the liver, kidney and serum samples. The significant enhancement of the test item concentration after enzymatic hydrolysis in the serum, liver and kidney samples implies that the liver is the major organ responsible for metabolism and that the kidney plays an important part in the excretion of its metabolites. The highest level of bisphenol-AF was observed in the faeces, which indicates that most of the test item was excreted as the nonconjugated form. Faecal excretion was the major route of elimination, and urinary excretion was the secondary route.
Results were determined using a validated method where fortified samples, performed at three fortification levels, were extracted to confirm the sensitivity of the extraction and analytical methods. The mean recoveries ranged from 71.0 % to 102.3 % with relative standard deviations of no more than 13.2 % (n = 6) and the limit of quantification was determied to be 1 µg/kg for liver, muscle, adipose, kidney and urine samples and 3 µg/kg for faeces. Reported values indicate an adequately efficient and sensitive method.
This metabolism study in the rat is classified acceptable and satisfies the guideline requirement for a metabolism study OECD 417 in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.